From Aesthetic Medicine to Transdermic Technology: Introducing new skincare brand Labo Transdermic

Dubai, UAE, March 9, 2017:  Labo Crosprophar Suisse, a renowned Swiss brand offering research based cosmetic products, is bringing to the UAE their new and innovative skincare range, Labo Transdermic. The range is equipped to provide effective solutions to various problems associated with aging skin.  

The new Transdermic Technology that lies behind the products of the Labo Transdermic range, acts as an effective alternative to skin-tightening and Botox injections performed in aesthetic medicine. Formulated with 8 hyaluronic acids and other functional active substances, the very low molecular weight provides the skincare range with the capability to enter deep into the skin. The product’s ability to penetrate the dermis and actively combat the symptoms of aging skin and wrinkles without invasion makes it a world first in the dermo-cosmetic field based on the Transdermic Technology. 

Labo Transdermic is set to consist of five ranges of products fundamental to tackling dermal problems associated with maturing skin, including aging, wrinkling, hypersensitivity, dullness and dehydration, each of which will have four preparation of products. In addition to this, two other ranges have been curated specifically for total eye-care and daily facial cleansing purposes. The range also consists of two stand alone products, one being the Sunscreen Fluid Base SPF 50+, that can be used by itself or mixed with the Labo Transdermic cream to create a highly effective day cream, and the other being the 5 Actions Ultra Serum, which is a wise blend of active molecules that helps you to achieve a total-action transdermic treatment. 

Labo Transdermic will be available for purchase from leading pharmacies across the UAE including Bin Sina Pharmacy.